The Trump administration has finalized a new director for the Center for Medicare and Medicaid Innovation (CMMI): Adam Boehler, the former CEO of Landmark Health, a home-based medical care company.
The Trump administration has finalized a new director for the Center for Medicare and Medicaid Innovation (CMMI), CMS Administrator Seema Verma told staff via email last week.
Adam Boehler, the former CEO of Landmark Health, a home-based medical care company, will start as the director this week. His probable hiring was first reported by Politico in December; the report said the startup executive needed time to divest of certain investments.
The office was created by the Obama administration with the notion that it could pilot new ways for Medicare and Medicaid to pay for care to save money and make the healthcare system more efficient. However, it had drawn criticism for mandatory initiatives, such as bundled payment models, and for not engaging enough stakeholders in the process.
The Trump administration has largely backed off bundled payments while Verma has said she wants a new direction for CMMI who will “promote greater flexibility and patient engagement.”
“Adam is widely regarded as an innovative leader in the private sector and in him we are lucky to have someone who has designed and implemented new, patient-focused approaches to healthcare delivery,” Verma wrote to CMS staff.
HealthExec said Boehler's background also includes running another healthcare startup, lab management company Accumen. Other past roles include executive vice president and general manager at analytics provider MedeFinance and a principal healthcare investor at Accretive.
NAACOS Continues Pushing Forward on the Transition to Value-Based Care
September 21st 2020Allison Brennan, MPP, discusses legislation that would affect accountable care organizations (ACOs), the impact coronavirus disease 2019 had on ACOs, and the fall National Association of ACOs meeting.
Listen
Examining Physician-Initiated Alternative Payment Models, a New Wave of Payment Reform
September 12th 2019To date, most alternative payment models (APMs) that have emerged in the shift toward value-based care have been initiated by payers and focused on primary care providers. However, there has recently been a new wave of payment reform in which providers, mostly specialists, are designing and implementing their own APMs in their practices. A study published in the September issue of The American Journal of Managed Care® analyzed some of these new payment models to gain insight into what providers are prioritizing in their APMs.
Listen
Clinical Trials Won’t Cause Financial Harm for Practices in Medicare Payment Models, Study Finds
June 28th 2024Ishwaria Subbiah, MD, of SCRI Oncology Partners, discusses new findings presented at ASCO 2024. This interview will appear in the annual ASCO recap issue of Evidence-Based Oncology.
Read More